Treatment of chronic hepatitis C virus infection in Japan: update on therapy and guidelines.
Chayama K, Hayes CN, Ohishi W, Kawakami Y.
J Gastroenterol. 2013 Jan;48(1):1-12. doi: 10.1007/s00535-012-0714-9. Epub 2012 Nov 28.
Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients: A systematic review and meta-analysis of longitudinal studies.
Kamal H, Fornes R, Simin J, Stål P, Duberg AS, Brusselaers N, Aleman S.
J Viral Hepat. 2021 Oct;28(10):1431-1442. doi: 10.1111/jvh.13577. Epub 2021 Jul 28.
Optimizing triple therapy and IFN/RBV-free regimens for hepatitis C virus infection.
Chayama K, Mitsui F, Hayes CN.
Expert Rev Gastroenterol Hepatol. 2015 Jan;9(1):21-30. doi: 10.1586/17474124.2015.960394. Epub 2014 Sep 14.
Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates.
Mehawej M, Rostaing L, Alric L, Del Bello A, Izopet J, Kamar N.
J Transplant. 2015;2015:159795. doi: 10.1155/2015/159795. Epub 2015 Jul 16.
Hepatitis delta and HIV infection.
Calle Serrano B, Manns MP, Wedemeyer H.
Semin Liver Dis. 2012 May;32(2):120-9. doi: 10.1055/s-0032-1316467. Epub 2012 Jul 3.
Hepatitis delta: immunopathogenesis and clinical challenges.
Grabowski J, Wedemeyer H.
Dig Dis. 2010;28(1):133-8. doi: 10.1159/000282076. Epub 2010 May 7.
HBV, HCV, and HDV Triple-Infection-A Therapeutic Challenge.
Balta AAS, Ignat MD, Barbu RE, Baroiu L, Moroianu LA, Lutenco V, Bulza V, Patriciu M, Dumitru C, Debita M.
Diseases. 2025 May 26;13(6):168. doi: 10.3390/diseases13060168.
Prevalence, Risk Factors, and Clinical Profiles of Hepatitis D Virus in Nigeria: A Systematic Review, 2009-2024.
Adepoju VA, Udah DC, Adnani QES.
Viruses. 2024 Oct 31;16(11):1723. doi: 10.3390/v16111723.
Boceprevir for chronic HCV genotype 1 infection in treatment-experienced patients with severe fibrosis or cirrhosis: The Greek real-life experience.
Manolakopoulos S, Kranidioti H, Goulis J, Vlachogiannakos J, Elefsiniotis J, Kouroumalis EA, Koskinas J, Kontos G, Evangelidou E, Doumba P, Sinakos E, Vafiadou Ι, Koulentaki M, Papatheodoridis G, Akriviadis E.
Ann Gastroenterol. 2015 Oct-Dec;28(4):481-6.
Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
Liaw YF, Tsai SL, Sheen IS, Chao M, Yeh CT, Hsieh SY, Chu CM.
Am J Gastroenterol. 1998 Mar;93(3):354-9. doi: 10.1111/j.1572-0241.1998.00354.x.
